CLX at a glance
Clorox (CLX, SEC CIK 21076) filed its latest 10-K annual report on August 7, 2026, a 10-Q quarterly report on April 30, 2026, an 8-K current report on August 3, 2026 and Form 4 insider filings as recently as October 2, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.
- For the fiscal year ended June 30, 2025 (FY2025), Clorox (CLX) reported revenue of $7.1 billion (up 0.2% from FY2024) and net income of $810.0 million. Diluted EPS was $6.52.
- As of June 30, 2026, 46 institutional investment managers tracked by SignalX reported holding Clorox (CLX) shares worth $5.4 billion in 13F-HR filings.
Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).
- Revenue · FY2025
- $7.1B
- +0.2% vs prior year
- Insiders · 90 days
- 0 buys · 0 sells
- No open-market trades
- 13F holders
- 46 funds
- $5.4B · −1 vs prior quarter
- Latest 8-K
- Aug 3, 2026
- Item 7.01 · Item 2.02
AI 10-K Annual Report Analysis
Latest 10-K, fiscal year ended Jun 30, 2026
Risk Factors
- Section 'risk_factors' was empty or not found.
Management Discussion & Analysis
- Revenue details not explicitly stated; focus on cash flows: Operating cash flow $612M in 2026 vs. $981M in 2025, decrease due to Venture Agreement and lower cash earnings
- Operating margin or profit metrics not provided; adjusted free cash flow 13.1% of net sales in 2026 vs. 10.7% in 2025
- Best performing segment details not disclosed; largest cash outflow from investing activities $2,301M in 2026 mainly due to GOJO acquisition
- Financing cash flow $1,668M in 2026 vs. $(924)M in 2025 driven by higher borrowings for GOJO; Stock repurchases $254M; Dividends per share $4.96 in 2026, up from $4.88 in 2025
- Management expects sufficient liquidity supported by positive future cash flow, strong credit ratings (S&P: A-2/BBB+), and available revolving credit lines totaling $1,964M
Business Overview
- Core business model: Multinational manufacturer and marketer of consumer and professional products with $6.7B net sales, 9,200 employees across 25 countries (FY 2026)
- New acquisition: April 2026 acquisition of GOJO, expanding health and hygiene segment and B2B channels, including Purell brand and dispensing systems
- Strategic shift: Expiration of P&G joint venture in January 2026; acquired full ownership of Glad business, increasing standalone operational responsibility
- Quantitative metric: $580 million invested in transformational technologies including new ERP system completed in Q3 FY 2026; employee count increased due to GOJO acquisition
- Noteworthy fact: Recordable incident rate (RIR) of 0.63 in FY 2026, significantly below 2024 U.S. goods manufacturing average of 2.7, highlighting strong employee safety performance
AI summary of the CLX 10-K filed . Generated from the filing text; verify against the original.View on SEC EDGARHow to read a 10-K
AI 10-Q Quarterly Report Analysis
Latest 10-Q, quarter ended Mar 31, 2026
Management Discussion & Analysis
- ERP transformation investment approximately $580 million; GOJO acquisition closed April 1, 2026
- Volatile, challenging outlook from macroeconomic uncertainty, tariffs, conflicts and potential gross-margin pressures
AI summary of the CLX 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K
AI 8-K Current Report Analysis
The most recent material events, by 8-K item
Item 7.01: Regulation FD Disclosure
- Supplemental financial information furnished under Regulation FD
- Exhibit 99.2 contains the substantive disclosure for investor review
Item 2.02: Results of Operations and Financial Condition
- Clorox reported fourth-quarter and fiscal-year results for the period ended June 30, 2026
- Financial details and management commentary appear in Exhibit 99.1, the attached earnings release
Item EX-99.1: Item EX-99.1
- FY26 net sales fell 5% to $6,720 million, with organic sales down 8% and organic volume down 7%
- Q4 organic sales declined 13%, led by Household down 18% and Lifestyle down 17%
Item 5.02: Departure/Appointment of Directors or Principal Officers
- Officer or director appointment referenced, but the provided excerpt does not identify the appointee or role
- No reportable related-party transactions under Regulation S-K Items 401(d) or 404(a)‑
Item 7.01: Regulation FD Disclosure
- Regulation FD filing furnishes a press release as Exhibit 99.1
- Exhibit 99.1 contains the substantive developments relevant to investors
Item EX-99.1: Item EX-99.1
- Simplified structure consolidates business-unit leadership under Chris Hyder as COO, targeting faster execution and stronger operational accountability
- Nina Barton becomes chief growth and strategy officer, overseeing innovation, commercial functions, and portfolio shaping
Item 5.02: Departure/Appointment of Directors or Principal Officers
- CEO Linda Rendle initiating succession search, creating near-term leadership uncertainty
- Rendle remaining Chair and CEO until successor appointment, limiting immediate operational disruption
Item 7.01: Regulation FD Disclosure
- Comprehensive CEO search initiated by the board
- CEO Ms. Rendle to depart after successor appointment
AI summaries of CLX 8-K current reports filed with the SEC. What 8-K item codes mean
SignalX for CLX
Don't miss the next CLX filing
- Alerts as it files. A push when CLX files an 8-K or an insider trades.
- Fund moves. Which tracked funds opened, added or cut CLX, by share count.
- Ask anything. An AI agent that reads every CLX filing and answers with sources.
CLX alerts on your phone. Follow it in the SignalX Android app.
Recent Insider Transactions (Form 4)
Latest reported trades by officers, directors and 10% owners
| Insider | Type | Date | Shares | Price |
|---|---|---|---|---|
| WEINER RUSSELL J | A | Sep 30, 2026 | 416.615 | - |
| WILLIAMS CHRISTOPHER J | A | Sep 30, 2026 | 339.464 | - |
| Plaines Stephanie | A | Sep 30, 2026 | 339.464 | - |
| Breber Pierre R | A | Sep 30, 2026 | 416.615 | - |
| Shattock Matthew J | A | Sep 30, 2026 | 648.068 | - |
| Marriner Kirsten | A | Sep 23, 2026 | 12,389 | $83.94 |
| Hyder Chris T | A | Sep 23, 2026 | 13,342 | $83.94 |
| Hilt Angela C | A | Sep 23, 2026 | 11,436 | $83.94 |
Financial SummaryXBRL
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Profitability | |||
| Revenue | - | $7.1B | $7.1B |
| Gross Profit | $2.9B | $3.0B | $3.2B |
| Net Income | - | $280.0M | $810.0M |
| Gross Margin | - | 43.0% | 45.2% |
| Net Margin | - | 3.9% | 11.4% |
| Balance Sheet | |||
| Total Assets | $5.9B | $5.8B | $5.6B |
| Equity | - | $328.0M | $321.0M |
| ROE | - | 85.4% | 252.3% |
| Per Share | |||
| EPS | $1.20 | $2.25 | $6.52 |
| Cash Flow | |||
| Operating CF | - | $695.0M | $981.0M |
| CapEx | $228.0M | $212.0M | $220.0M |
Source: XBRL data in Clorox (CLX)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →
13F Fund Holdings: Quarterly Trend
Latest: Q2 2026Aggregate CLX share value held by 13F filers tracked by SignalX, by quarter.
Quarterly totals table
| Quarter | Funds | Total value |
|---|---|---|
| Q2 2026 | 46 | $5.40B |
| Q1 2026 | 47 | $5.59B |
| Q4 2025 | 45 | $5.57B |
| Q3 2025 | 46 | $6.88B |
| Q2 2025 | 46 | $6.51B |
| Q1 2025 | 44 | $5.69B |
| Q4 2024 | 42 | $5.66B |
| Q3 2024 | 35 | $3.10B |
- Millennium Management+1.38M (+200%)
- Invesco Ltd+1.15M (+24%)
- Wells Fargo & Co+516.5K (+82%)
- Bank of America Corp+477.9K (+34%)
- Raymond James Financial+433.6K (+164%)
- FMR LLC (Fidelity)−790.7K (-54%)
- AQR Capital Management−762.1K (-71%)
- Morgan Stanley−469.2K (-17%)
- Goldman Sachs Group−166.5K (-13%)
- BlackRock−127.4K (-1%)
Source: 13F-HR filings on SEC EDGAR (aggregated from 351 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work
CLX filing archive
AI analysis pages for each 10-K, 10-Q and 8-K
10-K annual reports
10-Q quarterly reports
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing date | Period | Analysis | SEC |
|---|---|---|---|---|
| 4 | Oct 2, 2026 | - | - | - |
| 4 | Oct 2, 2026 | - | - | - |
| 4 | Oct 2, 2026 | - | - | - |
| 4 | Oct 2, 2026 | - | - | - |
| 4 | Oct 2, 2026 | - | - | - |
| 4 | Sep 25, 2026 | - | - | - |
| 4 | Sep 25, 2026 | - | - | - |
| 4 | Sep 25, 2026 | - | - | - |
| 4 | Sep 25, 2026 | - | - | - |
| 4 | Sep 25, 2026 | - | - | - |
| 4 | Sep 25, 2026 | - | - | - |
| 4 | Sep 25, 2026 | - | - | - |
| 10-K | Aug 7, 2026 | Jun 30, 2026 | Analysis | |
| 8-K | Aug 3, 2026 | - | Analysis | - |
| 4 | Jul 24, 2026 | - | - | - |
| 4 | Jul 17, 2026 | - | - | - |
| 4 | Jul 2, 2026 | - | - | - |
| 4 | Jul 2, 2026 | - | - | - |
| 4 | Jul 2, 2026 | - | - | - |
| 4 | Jul 2, 2026 | - | - | - |
| 4 | Jul 2, 2026 | - | - | - |
| 4 | Jun 22, 2026 | - | - | - |
| 4 | Jun 22, 2026 | - | - | - |
| 4 | Jun 22, 2026 | - | - | - |
| 4 | Jun 22, 2026 | - | - | - |
Related Consumer Staples companies
- ACI · Albertsons Companies IncRetail-Grocery Stores
- MO · AltriaCigarettes
- ANDE · Andersons, Inc.Wholesale-Farm Product Raw Materials
- BUD · Anheuser-Busch InBev SA/NVMalt Beverages
- ADM · Archer Daniels MidlandFats & Oils
- ARKO · ARKO Corp.Retail-Convenience Stores
- BGS · B&G Foods, Inc.Food and Kindred Products
- BYND · BEYOND MEAT, INC.Food and Kindred Products
CLX SEC filings: frequently asked questions
Which institutions hold CLX stock?
As of June 30, 2026, the largest Clorox (CLX) holders among the 13F filers tracked by SignalX were BlackRock ($958.6 million), State Street Corp ($804.8 million), Vanguard Capital Management LLC ($753.6 million), Invesco Ltd ($573.6 million), Vanguard Portfolio Management LLC ($553.5 million). 13F-HR reports are filed up to 45 days after each quarter ends.
What was CLX's revenue in fiscal year 2025?
For the fiscal year ended June 30, 2025 (FY2025), Clorox (CLX) reported revenue of $7.1 billion (up 0.2% from FY2024) and net income of $810.0 million. Diluted EPS was $6.52. The figures come from the XBRL data in the 10-K.
What are the main risks in CLX's latest 10-K?
In the 10-K filed August 7, 2026, Clorox (CLX) flagged: Section 'risk_factors' was empty or not found. (AI summary of the Risk Factors section.)
What did CLX report in its latest 8-K?
Clorox (CLX) filed an 8-K on August 3, 2026 reporting Item 7.01 (Regulation FD Disclosure) and Item 2.02 (Results of Operations and Financial Condition). Supplemental financial information furnished under Regulation FD.
What are the latest CLX SEC filings?
Clorox (CLX) filed its latest 10-K annual report on August 7, 2026, a 10-Q quarterly report on April 30, 2026, an 8-K current report on August 3, 2026 and a Form 4 insider filing on October 2, 2026.
What is CLX's SEC CIK number?
Clorox (CLX)'s SEC Central Index Key (CIK) is 21076. EDGAR lists every CLX filing under that number.
Ask anything about CLX
The research agent reads CLX's filings, financials, insider trades and 13F holders, then answers with sources.